Synaptogenix Share Price Today
(NASDAQ: SNPX)

Name: Synaptogenix Share Price Today (NASDAQ: SNPX) - Synaptogenix Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Synaptogenix share price is $2.84 & ₹246.99 as on 6 Mar 2025, 2.30 'hrs' IST

$2.84

▲

0.13

(4.83%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Synaptogenix share price in Dollar and Rupees. Guide to invest in Synaptogenix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Synaptogenix, along with analyst recommendations, forecasts, and comprehensive financials.

Synaptogenix share price movements

Today's Low: $2.84
Today's High: $2.87
$2.84
0.1%
Downside
Day's Volatility :1.3%
Upside
1.21%
52 Weeks Low: $2.32
52 Weeks High: $6.22
$2.84
18.31%
Downside
52 Weeks Volatility :62.68%
Upside
54.32%

Synaptogenix (SNPX) Returns

Period	Synaptogenix Inc	Index (Russel 2000)
3 Months	-8.56%	0.0%
6 Months	-23.97%	0.0%
1 Year	-41.7%	0.0%
3 Years	-58.43%	-11.6%

Synaptogenix (SNPX) Key Statistics

in dollars & INR

Previous Close	$2.7065
Open	$2.8747
Today's High	$2.8747
Today's Low	$2.8373
Market Capitalization	$4.1M
Today's Volume	$8.9K
52 Week High	$6.217
52 Week Low	$2.32
Revenue TTM	$0.0
EBITDA	$-6.8M
Earnings Per Share (EPS)	$10.27
PE Ratio	0.29
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-7.5%

How to invest in Synaptogenix Stock (SNPX) from India?

It is very easy for Indian residents to invest directly in Synaptogenix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Synaptogenix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Synaptogenix or SNPX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Synaptogenix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Synaptogenix shares which would translate to 0.306 fractional shares of Synaptogenix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Synaptogenix, in just a few clicks!

Returns in Synaptogenix (SNPX) for Indian investors in Rupees

The Synaptogenix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Synaptogenix investment value today

Current value as on today

₹66,170

Returns

₹33,830

(-33.83%)

Returns from Synaptogenix Stock

₹38,793 (-38.79%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Synaptogenix (SNPX)

33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Synaptogenix Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Synaptogenix

Geode Capital Management, LLC
0.80%
UBS Group AG
0.24%
Tower Research Capital LLC
0.02%
Morgan Stanley - Brokerage Accounts
0.01%

Analyst Recommendation on Synaptogenix

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Synaptogenix(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Synaptogenix Stock (SNPX)

What analysts predicted

Upside of 392.96%

Target:

$14.00

Current:

$2.84

Insights on Synaptogenix Stock (Ticker Symbol: SNPX)

Price Movement
In the last 7 days, SNPX stock has moved up by 1.4%
SNPX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 106.0%
SNPX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 106.9%

Synaptogenix Technicals Summary

Sell

Neutral

Buy

Synaptogenix is currently in a neutral trading position according to technical analysis indicators.

Synaptogenix (SNPX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Synaptogenix Inc	-6.35%	-23.97%	-41.7%	-58.43%	-60.49%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Synaptogenix Inc	0.29	0.29	NA	-7.48	-0.07	-0.14	NA	14.99
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Synaptogenix Inc	Sell	$4.1M	-60.49%	0.29	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Synaptogenix

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York.

Organization	Synaptogenix
Employees	5
CEO	Dr. Alan J. Tuchman M.D., MBA(FAAN)
Industry	Miscellaneous

Management People of Synaptogenix

Name	Title
Dr. Alan J. Tuchman M.D., MBA(FAAN)	CEO & Director
Dr. Daniel L. Alkon M.D.	President, Chief Scientific Officer & Director
Mr. Robert Weinstein	CFO, Executive VP, Treasurer & Secretary

Important FAQs about investing in SNPX Stock from India :

What is Synaptogenix share price today?

Synaptogenix share price today stands at $2.84, Open: $2.87 ; Previous Close: $2.71 ; High: $2.87 ; Low: $2.84 ; 52 Week High: $6.22 ; 52 Week Low: $2.32.

The stock opens at $2.87, after a previous close of $2.71. The stock reached a daily high of $2.87 and a low of $2.84, with a 52-week high of $6.22 and a 52-week low of $2.32.

Can Indians buy Synaptogenix shares?

Yes, Indians can invest in the Synaptogenix (SNPX) from India.

With INDmoney, you can buy Synaptogenix at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Synaptogenix at zero transaction cost.

How can I buy Synaptogenix shares from India?

It is very easy to buy Synaptogenix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Synaptogenix (SNPX) be purchased?

Yes, you can buy fractional shares of Synaptogenix with INDmoney app.

What are the documents required to start investing in Synaptogenix stocks?

To start investing in Synaptogenix, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.